PXAI UK Audio Feed
31/05 15:02 independent.co.uk

New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer

dual-action drugsquamous non‑small cell lung cancerhard‑to‑treatclinical trialstumour shrinkagesurvival rates
22/05 06:08 independent.co.uk

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP‑1OzempicWegovycancer outcomesobesity‑related cancerstumor growth
14/05 14:05 independent.co.uk

New stomach cancer drug approved for NHS use in ‘first major advance’ in treatment in a decade

NHSstomach cancerimmunotherapydrug approvaltreatment advanceclinical trials
07/05 11:05 independent.co.uk

Promising drug found to double survival rate for advanced pancreatic cancer patients

pancreatic cancerdrug therapysurvival rateclinical trialoncologyadvanced disease
30/04 08:00 scotsman.com

East Lothian schoolgirl among youngsters to benefit from gentler leukaemia treatment

leukemiapediatric oncologyGreat Ormond Street Hospitalgentler treatmentsurvival ratesquality of life
21/04 00:30 independent.co.uk

New bowel cancer immunotherapy treatment ‘highly effective’ in improving survival rates

bowel cancerimmunotherapysurvival rateszero relapsesclinical trialbreakthrough treatment
20/04 19:00 dailymail.co.uk

Home spit test could spot early signs of stomach cancer, which is often diagnosed too late due to 'vague' symptoms, claims new study

stomach cancerearly detectionsaliva testhome screeninglate diagnosisnon-invasive
14/04 13:26 dailymail.co.uk

Pancreatic cancer breakthrough as scientists develop new drug that 'doubles survival rate' of silent killer

pancreatic cancerdrug breakthroughsurvival ratesilent killerearly detectiononcology
13/04 19:38 independent.co.uk

New pancreatic cancer drug nearly doubles survival time in patients

pancreatic cancerdrugsurvivaloncologybreakthroughtreatment
13/04 19:38 independent.co.uk

New pancreatic cancer drug nearly doubles survival time in patients

pancreatic cancerdrugsurvivaloncologybreakthroughtreatment
UK Cluster Comments
Loading UK comments...
0